Nalaganje...
Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST
BACKGROUND: In the Beta-Blocker Evaluation of Survival Trial (BEST) trial, systolic blood pressure (SBP) ≤120 mm Hg was an independent predictor of poor prognosis in ambulatory patients with chronic systolic heart failure (HF). Because SBP is an important predictor of response to beta-blocker therap...
Shranjeno v:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3769783/ https://ncbi.nlm.nih.gov/pubmed/21982425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjca.2011.07.004 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|